Andere talen Landos Biopharma, Inc.

Aandelen

LABP

US5150692011

Beurs gesloten - Nasdaq Andere beurzen 22:30:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
22,3 ^USD	-0,80%		+0,68%	+509,29%

01/04	LANDOS BIOPHARMA, INC. : HC Wainwright verlaagt advies naar Neutraal	ZM
25/03	Deals van de dag - Fusies en overnames	RE

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie	16/04
North American Morning Briefing : Stocks Seen -2-	02/04
LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP	27/03
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Landos Biopharma, Inc - LABP	27/03
Deals of the day-Mergers and acquisitions	25/03
Sector Update: Health Care Stocks Decline Late Afternoon	25/03
INVESTIGATION ALERT: Halper Sadeh LLC Investigates LABP, FUSN, KNTE	25/03
Top Midday Gainers	25/03
Sector Update: Health Care Stocks Softer in Afternoon Trading	25/03
Shareholder Alert: Ademi LLP investigates whether Landos Biopharma, Inc. has obtained a Fair Price in its transaction with AbbVie	25/03
LABP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Landos Biopharma, Inc. Is Fair to Shareholders	25/03
AbbVie to Acquire Landos Biopharma For About $137.5 Million; Landos Shares Jump	25/03
Landos Biopharma Shares Surge 178% on Takeover Deal With AbbVie	25/03
AbbVie in Deal to Acquire Landos Biopharma for $137.5 Million	25/03
AbbVie to Acquire Landos Biopharma for About $137.5 Million	25/03
AbbVie to Acquire Landos Biopharma for About $137.5 Million	25/03
AbbVie to buy Landos to expand pipeline of immunity-related illnesses	25/03
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases	25/03
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases	25/03
AbbVie Inc. agreed to acquire Landos Biopharma, Inc. on March 24, 2024.	25/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Landos Biopharma, Inc.

Aandelen

LABP

US5150692011

Andere talen

Filters